Good morning. My name is Rob, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Healthcare Services Group Third Quarter 2023 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. The matters discussed on today's conference call include forward-looking statements about the business prospects of Healthcare Services Group, Inc. For Healthcare Services Group, Inc.'s most recent forward-looking statements notice, please refer to the press release issued this morning which can be found on our website at www.hcsg.com. Actual results may differ materially from those expressed or implied as a result of various risks, uncertainties and important factors, including those discussed in the risk factors MD&A and other sections of the Annual Report on Form 10-K and Healthcare Services Group, Inc.'s other SEC filings. Additionally, management will be discussing certain non-GAAP financial measures. A reconciliation of these items to US GAAP can be found in this morning's press release. Thank you. Ted Wahl, President and CEO, you may begin your conference.

Thank you and good morning, everyone. Matt McKee and I appreciate you joining us today. We released our third quarter results this morning and plan on filing our 10-Q by the end of the week. Today, in my opening remarks, I will first discuss our third quarter financial highlights and key accomplishments. Next, I will provide an update on recent client restructuring actions. I will then share our perspective on the latest industry trends and developments. And then finally, I will share our fourth quarter and 2024 outlook. So, with that overview, I'd like to now discuss our third quarter financial highlights and key accomplishments. For the three months ended September 30, 2023, we reported revenue of $411.4 million and adjusted revenue of $424 million, in line with our expectations of $420 million to $430 million. We reported a net loss and diluted loss per share of $5.5 million and $0.07 per share, and adjusted net income and adjusted diluted earnings per share of $12.5 million and $0.17 per share, a 13.9% and 13.3% increase respectively over Q3 2022. We reported adjusted EBITDA of $23.3 million, a 10.2% increase over Q3 2022, and we reported cash flow from operations of $2.9 million and adjusted cash flow from operations of $18 million, a 208.9% increase over Q3 2022. We entered the second half of the year with three clear priorities and made substantial progress on all three during the quarter. The first was continuing to manage adjusted cost of services at 86%, which we did. The second was collecting what we bill, building on the strong momentum that we gained in May and June. In Q3, we delivered our strongest cash collections of the year, collecting over 98% of what we billed, with the modest shortfall primarily related to the timing of new business adds during the quarter. The third priority was executing on our organic growth strategy. Adjusted revenue for the quarter was up sequentially, our sales pipeline is growing, and our recruiting and management development efforts are ramping up as we ready ourselves for growth. Now, moving on to some of the recent client restructuring actions, we had two long-term clients initiate restructurings during the quarter. As part of their restructuring actions, these customer groups divested facilities to new operators. We're pleased to report that we've entered into new agreements with those new operators to retain the business and ensure many more years of partnership. As a result, we expect a neutral-to-positive effect on future revenue and earnings related to these facilities. These client downsizing actions are in line with the ongoing shift in the sector from large multi-state operators to smaller regional operators. This shift is very good for us for many reasons, not the least of which is the diversity of AR risk. I would also add that, notably, Genesis is not one of the restructurings. We continue to be very encouraged by the positive direction of their organization as they work towards their goal of having a leaner, healthier regional footprint, and with our most recent conversations regarding our partnership going forward, both operationally and financially. I'd like to now share our perspective on the latest industry trends and developments. As we look towards 2024, industry fundamentals continue to improve. A stabilizing labor market and select state-based reimbursement increases have contributed to the gradual but steady occupancy recovery. On the regulatory front, on September 1, CMS proposed the minimum staffing rule, which triggered a 60-day comment period that will remain open until November 6, 2023. A final rule is expected mid-2024. There is a growing list of stakeholders opposed to the rule, including health care industry leaders, trade associations like ACA, MedPAC members and a bipartisan group of legislators, including 28 senators and counting. The reasons for their opposition include the unfunded nature of the mandate, the one-size-fits-all approach, the apparent disregard for the realities of present and future nursing availability, and the near certainty that, if implemented as proposed, the rule would lead to facility closures and ultimately reduce access to care, particularly in rural areas. In addition to the public comment period, any rule would have to survive an onslaught of litigation, political changes in administration, and at least on some level would be funded. From our perspective, there remains great uncertainty as to whether any final rule would ultimately be implemented, at least one that resembles the current proposal. As far as our outlook for the fourth quarter in 2024, we enter Q4 with three clear priorities. The first is continuing to manage adjusted cost of services in line with our target of 86%. The second is collecting what we bill, building on the strong momentum gained in May, June and Q3. We're raising our expectations for second-half 2023 cash flow from operations from $20 million to $30 million to what is now $35 million to $45 million. The third priority is continuing to execute on our organic growth strategy. Our Q4 adjusted revenue estimated range is $420 million to $430 million. We look forward to ending the year on a strong note and expect our positive operating cash collection and new business trends to continue into 2024. So, with those introductory comments, I'll turn the call over to Matt for a more detailed discussion on the quarter, including our basis for GAAP to non-GAAP reporting.

Thank you, Ted, and good morning, everyone. For those of you who saw the press release this morning, you might have noticed that we introduced supplemental non-GAAP financial tables. The rationale for these supplemental schedules is to enhance transparency by providing even greater visibility into current business trends to increase period-to-period comparability and will closely align our reporting with how management views the business. So, with that context, I'd like to now move on to a more detailed discussion of the quarter. Revenue was $411.4 million. Adjusted revenue was $424 million. Housekeeping & Laundry and Dining & Nutrition segment revenues were $190.9 million and $220.5 million respectively. Adjusted Housekeeping & Laundry and Dining & Nutrition segment revenues were $194.6 million and $229.4 million, respectively. Housekeeping & Laundry and Dining & Nutrition segment margins were 5.4% and 0.9% respectively. Adjusted Housekeeping & Laundry and Dining & Nutrition segment margins were 7.2% and 4.7% respectively. Cost of services was $377.6 million. Adjusted cost of services was $366.2 million or 86.4%, in line with our target of 86%. And our goal is to continue to manage adjusted cost of services in the 86% range. SG&A was $39.0 million. Adjusted SG&A was $40.3 million or 9.5%, within the company's targeted range of 8.5% to 9.5%. And we expect to continue to manage adjusted SG&A within that targeted range. Third quarter cash flow and adjusted cash flow from operations were $2.9 million and $18.0 million, respectively. As Ted mentioned in his opening remarks, we raised our expectations for second-half 2023 cash flow from operations from $20 million to $30 million to $35 million to $45 million. DSO for the quarter was 82 days. Adjusted DSO was 79 days, a four-day improvement over last quarter. Also, as part of our adjusted results, we adjust for the impact of the change in payroll accrual. But since it will still be included in our reported cash flow from operations, we would point out that the Q4 payroll accrual is 15 days. That compares to the seven days that we had in the third quarter of 2023 and 14 days that we had in the fourth quarter of 2022. But again, the payroll accrual only relates to quarter-to-quarter timing. So, with those opening remarks, we'd now like to open up the call for questions.

Yes, thanks. Good morning. Maybe just starting with the impact of the two restructurings, Ted, you said some of the facilities were divested, but you signed contracts with the new operators. Did either of those new agreements contribute any revenue in the quarter? I guess just looking for a little bit of help squaring that with the revenue and the adjusted revenue you reported. Should we think about the $424 million of adjusted revenue number, is that the jumping-off point into Q4?

It is, Sean. Regarding the impact of restructurings, there was no significant effect aside from the temporary one-time decrease in revenue. Looking ahead, we believe there will be more opportunities because the divestiture of facilities played a major role in the restructuring efforts of both groups. This change allows us to work with new operators and smaller, more agile organizations, which positions us for future growth. That's why we anticipate that, from a revenue and earnings standpoint, this will be a neutral-to-positive outcome moving forward.

Okay, great. And then on the guidance for the cash from operations for the second half of the year, the $35 million to $45 million, is that an adjusted number or will that be GAAP? And then maybe if you could just walk us through the visibility you have into that? What gave you the confidence to raise that range?

That's to be consistent with how we presented it last quarter and the quarter before in terms of our second-half of the year expectations. We're just presenting and sharing a GAAP number. So, that's our revised range has moved from $20 million to $30 million to $35 million to $45 million. And in terms of our conviction around that number, I think it's a function of what we've talked about before. While the industry is still recovering, it hasn't fully recovered. We talked about coming into the year even on the heels of a strong Q4 last year. We expected some fits and starts on the collections front, especially in the beginning of the year, which is why we provided more modest cash flow estimates the first half of the year. But during the third quarter, and really starting in the second quarter, with May and June, we continued that strong momentum. This quarter, we collected over 98% of what we billed. The modest shortfall was really related to some of the startups we had intra-quarter. So, we have positive momentum heading into Q4. And visibility, Sean, visibility is a big thing in any business, including ours. So, I think the signals that Matt and I are trying to send to our investors and all of our stakeholders is we're continuing to gain visibility into our future performance, and that's what gives us conviction.

Okay. Great, thanks again, and congratulations on the progress in the quarter.

I appreciate it, Sean.

Great, good morning, gentlemen, appreciate you taking the time for my question here. And I guess, Matt, maybe I want to just dig into the 21.3, the item here in the reconciliation, just to get a little bit more color. It seems like there's two factors here. It looks like some of the revenue recognition that you talked to in the prior question. But also a component that's just, I guess I'd just call it bad debt write-downs judging from the footnote. Can you just tell me how much 21.7 was, what would be considered the bad debt write-down?

Sean, this is Ted speaking. The 12.5 figure would have influenced our revenue, while the rest would be related to bad debt. This is simply due to the accounting guidance. We still have a partial ongoing relationship with a smaller, more efficient operation that the existing customer is handling. Therefore, we have accounted for the existing customer as a one-time revenue decrease in this quarter. On the other hand, the restructuring has been separated out to two different operators, and since that involves a former customer, it is recorded as bad debt. It’s mainly a geographic issue in terms of our profit and loss statement, but from our perspective, it is a similar non-cash one-time impact related to legacy issues.

Got it. So, then I guess the question is from a process point of view, given that you've got about $9 million of kind of bad debt, is this idea of adjusted revenue that's going to add back some of the bad debt unique to the circumstance of this quarter? Or should we expect that this is a metric that you're going to report on an ongoing basis?

We would believe it's going to be circumstance driven. I would expect in most, if not just about every quarter, it would be a zero in terms of the adjusted revenue. But we at least wanted to introduce that possibility because again, the accounting rules for revenue are pretty clear. I believe it's ASC 606, that if you're in a negotiation and you're accepting getting paid less on what you had previously billed, and that's with an existing customer that you continue to provide some level of services to, then you're expected to record that adjustment as a reduction to revenue rather than bad debt expense. So, to the extent an incident like that or an action like that happens in the future, we would account for it in accordance with the guidance. But otherwise, we wouldn't expect it to be a recurring theme moving forward.

Okay, that makes sense. Ted, can you elaborate on the increased cash flow guidance? We understand your previous responses regarding visibility and confidence since May. Could you clarify if there was a collection on a past bad debt during the quarter or if there's something anticipated for the remainder of the year that contributes to this confidence for the increase?

No. It's really the inter-quarter collections and billings that gives us the confidence. And with that said, we continue to work on with our customers on plans, whether they're in hand and promissory notes. We've talked about before as an important tactic in our overall collection strategy, which can add a degree of tailwind to it, but there was nothing specific to this quarter or notable that would have been unusual. It was largely inter-quarter collecting what we bill. And again, a function of our strategy working, the increased payment frequency, the proactive use of promissory notes, and then discipline in our decision-making, coupled with, and perhaps even more importantly, Andy, the recovering environment. Every quarter that goes by, census occupancy continues to recover, and the state-based reimbursement benefits are starting to take hold. October is the first month that the 4% CMS increase would be realized. So you have a confluence of events that I think environmentally make for a stronger, a strengthening industry.

Okay. That's all really helpful perspective. Thank you, Ted. Have a good day.

Thanks, Andy.

Yes. Hey guys, this is Jack Senft on for Ryan Daniels. Thanks for taking my question. In terms of margins, it looks like both the housekeeping and laundry and then dining and nutrition segments decreased from last quarter on an adjusted basis. Is there anything to call out here that caused this decrease? Was it anything to do with restructuring? Or possible just even attributed to seasonality, just curious if you can kind of double click on that? Thanks.

Yes, more the latter than the former. Jack, there is always going to be some movement month to month, quarter to quarter depending on timing of new business adds or exits, management development ramp-ups, operational execution, and other considerations that are happening really each and every day as a part of our business within our field-based operations. Year-to-date, our adjusted segment margins are 8.8% and 5.6%, and we would expect to track in and around those levels for 2024, again, with a degree of that quarter-to-quarter variability. So, overall, we continue to have positive operational trends related to customer experience, system adherence, regulatory compliance, and budget discipline. All of which are near-term margin drivers, which is why we remain confident in our overall ability to continue to manage adjusted cost of services in that 86% range that we have targeted.

Thank you. I wanted to follow up on your comments about the sales pipeline, which you mentioned is increasing nicely and aligns with your growth phase. Could you provide more details about the sales pipeline? Specifically, I'd like to know what you're observing in terms of demand as you move into 2024.

Yes. We appreciate that question because as we have discussed previously, our value proposition continues to resonate more strongly than it ever has even historically. So, the demand for the services is absolutely there. And, not to suggest that increased demand necessarily yields an increased growth rate. But certainly to have greater demand allows us to be that much more selective in determining with whom we would like to establish new partnerships. And in many instances, expand our existing relationships. So, the demand for the services is certainly strong. We have built an organization on both the sales side of our field-based organization. And, also within our operations to develop the management pipeline such that we have the management capacity to be able to onboard new facilities. All of which are operating at full capacity right now. So, the demand we do anticipate will turn into new business growth and new business opportunities. Given that, we did talk about our expectations for the second half of the year to demonstrate top line growth sequentially relative to the first half of the year and we expect that growth trajectory to continue into 2024 such that we have every expectation that we see year-over-year growth in 2024 compared to this year.

Awesome. Thanks, Ted.

Your line is open. And there are no further questions at this time. I will turn the call back over to Ted Wahl for some final closing remarks.

Okay, great. Thank you, Rob. As we look ahead, we remain confident in our ability to control the controllables, realistic about the challenges that remain within our industry and broader economy, and focused on executing on our strategic priorities to drive growth and deliver long-term value to shareholders. So, on behalf of Matt and all of us at Healthcare Services Group, I wanted to again thank Rob for hosting the call today. And, thank you again everyone for joining.

This concludes today's conference call. Thank you for your participation. You may now disconnect.